DPPC Concludes Pharmex 2026 with a Strong and Impactful Presence

September 10, 2026

The third and final day of the 8th International Exhibition of Pharmaceutical Industries – Pharmex Middle East 2026 concluded with the active and enthusiastic presence of DPPC, alongside the company’s managers and employees.

Participation in Pharmex Professional Programs

Saeid Hajjari, CEO of DPPC, attended a number of Pharmex panels and professional programs in his capacity as a member of the Board of Directors of the Syndicate of Iranian Pharmaceutical Industries. Alongside other industry professionals and experts, he took part in discussions addressing specialized topics and the latest developments in the pharmaceutical sector.

Meanwhile, the deputies and managers of DPPC continued their engagement throughout the three-day exhibition by participating in professional meetings and discussions, pursuing opportunities for interaction and dialogue with domestic and international pharmaceutical companies and industry stakeholders.

Strong Employee Presence at the TIPICO Booth

The active participation and strong presence of DPPC employees was another notable feature of this year’s exhibition. Their presence created a dynamic and professional atmosphere and presented a cohesive picture of the company’s human and organizational capabilities.

A Role in the Closing Ceremony

At the Pharmex 2026 closing ceremony, Saeid Hajjari, in his capacity as a member of the Board of Directors of the Syndicate of Iranian Pharmaceutical Industries, along with several other prominent figures from the pharmaceutical industry, presented awards and certificates of appreciation to the exhibition’s selected participants.

With the closing ceremony, DPPC’s three-day presence at the 8th International Exhibition of Pharmaceutical Industries – Pharmex Middle East 2026 came to an end. The company’s participation, alongside professional engagements, business meetings, and involvement in the exhibition’s programs, provided an opportunity to strengthen professional relationships and showcase DPPC’s capabilities and potential within Iran’s pharmaceutical industry.